HAL (France)open access
Survival impact of [<sup>225</sup>Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases
Somatostatin analogs, Targeted alpha therapy, 2, 1, Neuroendocrine tumor, Actinium-225, PET/MRI, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 156016
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.